Fingerprint
Dive into the research topics of 'Osimertinib in patients with T790M-positive advanced non-small cell lung cancer: Korean subgroup analysis from phase II studies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Osimertinib in patients with T790M-positive advanced non-small cell lung cancer: Korean subgroup analysis from phase II studies
Myung Ju Ahn, Ji Youn Han, Dong Wan Kim, Byoung Chul Cho, Jin Hyoung Kang, Sang We Kim, James Chih Hsin Yang, Tetsuya Mitsudomi, Jong Seok Lee
Research output: Contribution to journal › Article › peer-review
1
Citation
(Scopus)